276 related articles for article (PubMed ID: 4215021)
1. Failure of disodium etidronate in calcinosis due to dermatomyositis and scleroderma.
Metzger AL; Singer FR; Bluestone R; Pearson CM
N Engl J Med; 1974 Dec; 291(24):1294-6. PubMed ID: 4215021
[No Abstract] [Full Text] [Related]
2. Disodium etidronate therapy for dystrophic cutaneous calcification.
Rabens SF; Bethune JE
Arch Dermatol; 1975 Mar; 111(3):357-61. PubMed ID: 804294
[TBL] [Abstract][Full Text] [Related]
3. Marked improvement of calcinosis in adult dermatomyositis with etidronate therapy.
Mori H; Okada Y; Yamaoka K; Saito K; Tanaka Y
J Bone Miner Metab; 2012 Jan; 30(1):114-8. PubMed ID: 21710176
[TBL] [Abstract][Full Text] [Related]
4. Focal mineralization defect during disodium etidronate treatment of calcinosis.
Weinstein RS
Calcif Tissue Int; 1982 May; 34(3):224-8. PubMed ID: 6809282
[TBL] [Abstract][Full Text] [Related]
5. Calcium balance in children treated with diphosphonates.
Uttley WS; Belton NR; Syme J; Sheppard H
Arch Dis Child; 1975 Mar; 50(3):187-90. PubMed ID: 167664
[TBL] [Abstract][Full Text] [Related]
6. [Extraosseous calcification in juvenile dermatomyositis. The ineffectiveness of EHDP].
Schneider HG; Minne HW; Raue F; Fichtner HJ; Baldauf G; Ziegler R
Dtsch Med Wochenschr; 1988 Aug; 113(33):1279-82. PubMed ID: 3137011
[TBL] [Abstract][Full Text] [Related]
7. Appearance of a gastric ulcer during diphosphonate therapy in a woman with CRST syndrome.
Saunders RL
South Med J; 1977 Nov; 70(11):1327-9. PubMed ID: 411174
[TBL] [Abstract][Full Text] [Related]
8. Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans).
Altman RD; Johnston CC; Khairi MR; Wellman H; Serafini AN; Sankey RR
N Engl J Med; 1973 Dec; 289(26):1379-84. PubMed ID: 4201876
[No Abstract] [Full Text] [Related]
9. Treatment of Paget disease of bone (osteitis deformans). Results of a one-year study with sodium etidronate.
Khairi MR; Johnston CC; Altman RD; Wellman HN; Serafini AN; Sankey RR
JAMA; 1974 Oct; 230(4):562-7. PubMed ID: 4213513
[No Abstract] [Full Text] [Related]
10. [Regression of severe periarticular calcifications during treatment with bisphosphonate in a dialysis patient].
Obad D; Larsen NA; Pedersen EB
Ugeskr Laeger; 2010 Mar; 172(9):719-21. PubMed ID: 20199755
[TBL] [Abstract][Full Text] [Related]
11. [Interstitial calcinosis of soft tissues in scleroderma and dermatomyositis].
Gordon IB; Shershevskiĭ MG; Bragina LM; Ol'shanskiĭ GS
Vopr Revm; 1966; 6(3):60-2. PubMed ID: 5993391
[No Abstract] [Full Text] [Related]
12. Regression of cutis calcinosis with diltiazem in adult dermatomyositis.
Abdallah-Lotf M; Grasland A; Vinceneux P; Sigal-Grinberg M
Eur J Dermatol; 2005; 15(2):102-4. PubMed ID: 15757822
[TBL] [Abstract][Full Text] [Related]
13. Pneumatosis intestinalis in collagen disorders.
Mueller CF; Morehead R; Alter AJ; Michener W
Am J Roentgenol Radium Ther Nucl Med; 1972 Jun; 115(2):300-5. PubMed ID: 5037791
[No Abstract] [Full Text] [Related]
14. Failure of warfarin in treatment of calcinosis universalis.
Lassoued K; Saiag P; Anglade MC; Roujeau JC; Touraine RL
Am J Med; 1988 Apr; 84(4):795-6. PubMed ID: 3400673
[No Abstract] [Full Text] [Related]
15. Proceedings: Use of diphosphonates in diseases associated with ectopic calcification.
Sheppard H; Uttley WS; Syme J; Belton N
Arch Dis Child; 1974 Oct; 49(10):828. PubMed ID: 4215374
[No Abstract] [Full Text] [Related]
16. Diltiazem induces remission of calcinosis in scleroderma.
Dolan AL; Kassimos D; Gibson T; Kingsley GH
Br J Rheumatol; 1995 Jun; 34(6):576-8. PubMed ID: 7633802
[TBL] [Abstract][Full Text] [Related]
17. Calcinosis universalis treated with disodium etidronate.
Spiro J; Gordon B
Clin Exp Dermatol; 1985 Mar; 10(2):181-2. PubMed ID: 3919976
[No Abstract] [Full Text] [Related]
18. Myositis ossificans progressiva. Clinical features of eight patients and their response to treatment.
Smith R; Russell RG; Woods CG
J Bone Joint Surg Br; 1976 Feb; 58(1):48-57. PubMed ID: 818090
[TBL] [Abstract][Full Text] [Related]
19. [A case of regressive development of diffuse calcinosis in the course of a dermatomyositis in a child].
Maurer JF; de Belleville-Séjourné AM; Chevallier J
Rev Rhum Mal Osteoartic; 1977 Nov; 44(11):661-6. PubMed ID: 601485
[No Abstract] [Full Text] [Related]
20. Treatment of calcinosis in juvenile dermatomyositis with probenecid: the role of phosphorus metabolism in the development of calcifications.
Harel L; Harel G; Korenreich L; Straussberg R; Amir J
J Rheumatol; 2001 May; 28(5):1129-32. PubMed ID: 11361202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
